Clinical Trial Update: Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating ranolazine versus placebo in patients with peripheral arterial disease and angina has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina
• Peripheral Arterial Disease

Drugs mentioned

• Ranolazine (ranolazine)

Snippet

Sponsor: Colorado Prevention Center | Conditions: Peripheral Arterial Disease, Angina | Phase 4 | Status: WITHDRAWN